Ivan Milanov, DSC graduated medicine in Sofia in 1981 and after that acquired specialty in Neurology. He specialized in movement disorders in the University of Kansas in the United States and in headache at the University of Pavia, Italy. Presently he is a Professor in neurology, National consultant of Ministry of Health in Neurology and consultant to the NHIF (National Health Insurance Fond), Corresponding Member of the Bulgarian Academy of Sciences, Board member and treasurer of the European Society of headache (EHS), Representative of Bulgaria on the board of the World Federation of Neurology (WFN), a member of the New York Academy of Sciences (NYAS) and the International Association for the Study of Pain (IASP - USA). Presently he is the CEO of University Hospital “St. Naum”. He was a Vice-Rector of the Medical University in Sofia from 2004 to 2008 and Deputy Minister of the Ministry of Health in 2010.

Clinical practice, Movement disorders, Multiple sclerosis, Pain, Headache, Clinical electromyography

Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of: Applied Clinical Cognitive Neuropsychology from USA. Prof. Dr. Aleezaadeh Completed his PhD Degrees in Psychology at the USA. He completed his master's Degree in Clinical Psychology at I. R. of the IRAN and bachelor's Degree in General Psychology at I. R. of the IRAN. He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (GreenLake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.

Cognitive Sciences, Cognitive Neurosciences, Neuroimaging, Applied Clinical Neuropsychology, Brain (Cranial) Imaging, Traditional Medicine, Combination of Medical, Psychological trends for eradicating illnesses / sicknesses

Ara Garabed Kaprelyan graduated from Higher Medical Institute of Varna in 1988. He is a Specialist in Neurology and Health Management, PhD since 2005, and Professor since 2013. Recently, he is a Chief of First Clinic of Neurology, member of Advisory Council (Neurology division) at University Multiprofi le Hospital for Active Treatment “Sveta Marina", Varna. He is an expert in MS, PD, AD, epilepsy, and chronic pain at National Health Insurance Fund and Republican Consultant of Ministry of Health for North-East region of Bulgaria. He is Head of Department of Neurologic Diseases and Neurosciences at Varna Medical University. His Postgraduate education includes specialization in neuro-oncology, clinical immunology, otoneurology, clinical epileptology, and movement disorders. He has over 150 scientifi c publications and authorship in eight medical text-books and monographs. He is a Member of Bulgarian Society of Neurology (Board of Managers; Chairman of regional branch at Varna district), Bulgarian Association of Neuro-oncology (Vice-president), International Medical Association Bulgaria, Balkan Medical Union (Vice-president of Bulgarian branch), and EAN (scientifi c panels of neuroepidemiology and neuro-oncology). He is in the Editorial Board of Journal of IMAB and Bulgarian Neurology, as well as a Correspondent member of Bulgarian Academy of Sciences and Arts.

Neurology, Neuro-oncology, Clinical Immunology, Movement disorders

Babak Kateb is a neuroscientist with more than 20 years of research experience. His research has been focused on introduction of advance diagnostics and therapeutics into clinical neuroscience in order to rapidly identify and introduce game changing technologies to treat neurological disorders such as brain cancer, Alzheimer’s disease, Parkinson’s disease, and other brain and spinal disorders. He did his educational training at TUSOM, USC, did his research fellowship at USC-keck School of Medicine, Department of Neurosurgery and also studied VLSI system design at USC Department of Electrical Engineering at the Ming Hsieh Institute. Babak established the Society for Brain Mapping and Therapeutics (SBMT) while doing his research fellowship 15 years ago at USC. Currently, he is the founding chairman of the board of directors & CEO Society for Brain Mapping and Therapeutics (SBMT), President and Scientific Director of the Brain Mapping Foundation and Director of National Center for Nano-Bio-Electronics; the center is focused on integration of nanotechnology, cellular therapeutics/stem cell, medical device and imaging; he is also a director of Brain Technology and Innovation Park and CEO of Smart Microscopy Inc.

Clinical Neuroscience, Brain cancer, Alzheimer’s disease, Parkinson’s disease, Brain stimulation

Max Leone is a professional speaker, coach and author who has been involved in the personal growth field for more than ten years. He studied with some of the greatest masters in the field, such as Wayne Dyer, Deepak Chopra, Neale Walsh, Anthony Robbins, Eckhart Tolle. Max studied NLP with the founder Richard Bandler, with whom he became a Certified Trainer of Neuro-Linguistic-Programming. He qualified and studied extensively a variety of disciplines such as Translation Analysis, ACT (Acceptance and Commitment Therapy), The Sylva Method, Hypnosis, DHE (Designing human Engineering) and other techniques he uses with individuals and groups. He has been interviewed on radio stations, such as New York Coaching Common Radio, 103.2, Radio Dublin, and his work has been featured in magazines and newspapers, among which are Positive Life, The Irish Times, New Thoughts Magazines, to mention some. Max is the author of "Daily Tips for Success & Fulfilment”.

Neuro Linguistic Programming, Brain

Kim Baden-Kristensen is the CEO and Co-founder of Brain+, which specializes in digital therapeutics for brain rehabilitation and remediation, specifically for the recovery of impaired cognitive functions due to injury or disease. It’s award winning Brain+ apps are being clinically tested in Parkinson’s disease, Major depressive disorder and Traumatic brain injury patients, and is being used by Danish national team athletes to enhance cognitive performance. Brain+ is also working on pre-symptomatic detection of Alzheimer’s disease in collaboration with leading European universities, providers, and patient organizations.

Cognitive Disorders, Brain Disorders

Dr. Giulio Maria Pasinetti, The Saunders Family Chair and Professor of Neurology, received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Director of the NIH funded Mount Sinai Center on the Promotion of Cognitive and Psychological Resilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He is also a Professor of Psychiatry, of Neuroscience, and of Geriatrics and Adult Development. Dr. Pasinetti is the recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. Most recently, Dr. Pasinetti was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.

Alzheimer's Disease Amyotrophic Lateral Sclerosis Diabetes Genomics Memory Obesity Parkinson's Disease

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

Parkinsion’s and Alzheimer’s Diseases

Alberto E. Musto, M.D. Ph.D. FAES, is a physician-scientist and medical educator of the Department of Pathology and Anatomy and Department of Neurolgoy of the Eastern Virginia Medical School, Virginia, USA. Dr. Musto’s scientific goal is to identify a potential biomarker and preventive therapies for epilepsy. Currently, his research is focusing in the cellular and molecular mechanisms of inmune-inflammatory process that contribute to the development of aberrant neuronal networks after brain injuries. He has been studied the role of pro-inflammatory mediators in experimental models of epilepsy using in vivo recordings of neural activities from chronically implanted microelectrodes in the brain and its correlations with neural damage, microglia cells and dendritic spines modifications using histological and biochemical approaches. He has been involved actively in medical education and neuroscience research in Universidad de Buenos Aires, and Universidad Austral, Argentina and Louisiana State University Health Sciences Center, USA supported by CONICET, Argentina and NIH, USA. Dr. Musto received board certifications in both neurology and radiology, completed postgraduate studies in medical education, and management in health systems in Argentina. He completed a doctoral thesis in neurobiology and a postdoctoral fellowship in neuroprotection in USA

Epilepsy, Neurology, Neuroradiology, Epidemiology

Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor he run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique (France), Institut Henri Poincare (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University and University of New Mexico). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA. Prof. R. Mutihac is member of the ISMRM, ESMRMB, OHBM, Romanian US Alumni Association, and fellow of Signal Processing and Neural Networks Society IEEE, as well as referee for several journals of the Institute of Physics (London, UK), Neural Networks (Elsevier), IEEE Transactions on Image Processing, and evaluator/expert for the ISMRM, OHBM, ARACIS, CNCSIS, UEFISCDI, The Romanian – U.S. Fulbright Commission. and the European Commission (FP7, H2020). He published over 100 scientific papers, 12 monographs, and contributed with chapters in other 10 text books. He contributed to more than 150 scientific meetings with posters and oral presentations, seminars, invited and plenary lectures, as well as acting as organizer, chairman, and keynote speaker

Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence

Birendra Kumar Bista is one of the first neurologists of Nepal. He has been pioneering in field of neuroscience in Nepal and established the first neuroscience center of eastern Nepal. Through years the work of this neuroscience center has been recognized home and abroad. He shows keen interest in medical management and providing state of art services to this impoverished region of Nepal. Recently he added the first stroke center of Nepal. He firmly believes in continuous updated education and its implementation in hospital practices.

Neurology, Stroke, Blood pressure

Rodney O. Leacock, M.D., neurointensivist at Palmetto Health Neurosurgery Associates, is board certified in neurology, neurocritical care and vascular neurology. Leacock received his medical degree from Howard University College of Medicine in Washington, D.C. and completed his neurology residency at Temple University Hospital in Philadelphia, Pennsylvania. He went on to complete a fellowship in neurocritical care at Wayne State University, Detroit Receiving Hospital in Detroit, Michigan and a stroke fellowship at Saint Louis University in Saint Louis, Missouri.

His clinical interests include acute ischemic stroke, intracranial and subarachnoid hemorrhage, status epilepticus, and airway protection in patients with neurological disorders. He specializes in caring for patients with complex neurological diseases.

Dr. Garcia joined Carilion in 2008 and was promoted to Section Chief of Body Imaging in 2009. She was appointed to her current position in 2011. Her major responsibility is to ensure clinical quality and safety for patients and staff. Prior to joining Carilion, Dr. Garcia was on staff at Pioneer Valley Hospital in West Valley City, Utah. She has given several presentations on radiology, imaging, radiation doses and advanced cardiac imaging with multi-detector CT. During her time at the University of Utah, she was the fourth-year Radiology Clerkship Director for the University of Utah School of Medicine. She holds medical licenses in Utah, Illinois, New Mexico and Virginia. Based on her outstanding academic performance in medical school, Dr. Garcia was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Garcia enjoys collaborating as a member of the multi-disciplinary TAVR team.

Neurology, Stroke, Neuroimaging

The Director of the Institute is Professor Pankaj Sharma. In addition to being its director he is also a consultant neurologist at Imperial College Healthcare NHS Trust. Professor Sharma holds a University of London Chair of Neurology at Royal Holloway. He is a former British Heart Foundation Clinician Scientist at Cambridge and a Fulbright Scholar at Harvard Medical School. He holds double doctorates from both the University of Cambridge and University of London. Most recently he led the internationally renowned Imperial College Cerebrovascular Research Unit at Imperial College London.

Professor Sharma’s research seeks to use genetics, genomics and proteomics to advance human understanding of cerebrovascular disease in three key areas: prediction, diagnosis and treatment of stroke at the molecular level. He has a particular interest in the genetics of stroke in ethnic minorities, particularly South Asians and Middle Eastern populations

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU. His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury.

George Perry is dean of the College of Sciences and the Semmes Foundation Distinguished University Chair in Neurobiology at The University of Texas at San Antonio. Dr. Perry is recognized in the field of Alzheimer’s disease research particularly for his work on oxidative metabolism. Dr. Perry is distinguished as one of the top Alzheimer’s disease researchers with over 1,000 publications, and one of the top 100 most-cited scientists in neuroscience and behavior (Over 68,000 citations, H=131), as well as the Expertscape Leading Expert in Alzheimer’s disease. Perry serves as editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Texas Academy of Sciences, and Microscopy Society of America, a Fulbright Senior Specialist, as well as a member of the Dana Alliance for Brain Initiatives. Perry is also recognized internationally: he is a Foreign Member of the Spanish Royal Academy of Sciences, the Academy of Science Lisbon, and the Mexican National Academy of Sciences. He is also a recipient of the National Plaque of Honor from the Republic of Panama Ministry of Science and Technology

Dr. Perry’s studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimer disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Current studies focus on the: mechanism for RNA-based redox metal binding consequences of RNA oxidation on protein synthesis rate and fidelity role of redox active metals in mediating prooxidant and antioxidant properties signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis mechanism of phosphorylation control of oxidative damage to neurofilament proteins

Dr. Giulio Maria Pasinetti, The Saunders Family Chair and Professor of Neurology, received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Director of the NIH funded Mount Sinai Center on the Promotion of Cognitive and Psychological Resilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He is also a Professor of Psychiatry, of Neuroscience, and of Geriatrics and Adult Development. Dr. Pasinetti is the recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. Most recently, Dr. Pasinetti was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.

Alzheimer's Disease Amyotrophic Lateral Sclerosis Diabetes Genomics Memory Obesity Parkinson's Disease

Giovanni Antioco Putzu is a Medical Doctor since 1992, with specialization in Paediatric Neurology. He achived his PhD in 1996. During PHD studies, He was a Research Fellow in Hammersmith Hospital of London, UK in 1992, then He moved in Marseille to work at INSERM (Genetics) and in Neurophathology. The Author has published more than 15 papers in the field of Neuromuscular Disorders.

Neurology, Neuromuscular Disorders

Superintendent of Yumin General Hosptial Co-Director Department of Neurology Changhua Chrisitian Hosptial National Delegate of Taiwan Neurological Society 18th President of Taiwan Neurological Society

Neurology

Walter Bini has completed his diploma from Westminster School, Simsbury Conn. U.S.A. and got postgraduate degree from Universidad de Zaragoza , Facultad de Medicina, Zaragoza-Spain. In 2014 he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery, Sheikh Khalifa General Hospital , UAQ-UAE from 2014-2016. Currently he is Consultant Neurosurgeon, Orthopedic Department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon, Orthopedic Department of Healthpoint Hospital in Abu Dhabi - UAE.

Neurology And Neurosurgery

Prof. Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor he run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique (France), Institut Henri Poincare (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University and University of New Mexico). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA. Prof. R. Mutihac is member of the ISMRM, ESMRMB, OHBM, Romanian US Alumni Association, and fellow of Signal Processing and Neural Networks Society IEEE, as well as referee for several journals of the Institute of Physics (London, UK), Neural Networks (Elsevier), IEEE Transactions on Image Processing, and evaluator/expert for the ISMRM, OHBM, ARACIS, CNCSIS, UEFISCDI, The Romanian � U.S. Fulbright Commission. and the European Commission (FP7, H2020). He published over 100 scientific papers, 12 monographs, and contributed with chapters in other 10 text books. He contributed to more than 150 scientific meetings with posters and oral presentations, seminars, invited and plenary lectures, as well as acting as organizer, chairman, and keynote speaker

Signal Processing, Microelectronics, and Artificial Intelligence

Alok Sharma is a Neurosurgeon and presently Professor & Head of Department of Neurosurgery at the LTMG Hospital & LTM Medical College, Director of the NeuroGen Brain & Spine Institute and Consultant Neurosurgeon at the Fortis Hospital in Mumbai , India. He has authored 12 books, edited 2 books, contributed chapters to 8 other books and has 83 scientifi c publications in medical journals. He has made 146 scientifi c presentations all over the world & has conducted several national and international trials and has been conferred with numerous honors and awards in his distinguished career. He has organized many international and national conferences and regularly conducts handson training workshops on Microvascular Surgery, Neuroendoscopy and Spinal fi xations. He has been committed to both basic as well as clinical research in attempting to fi nd an answer to the problems of paralysis and neurological defi cits that occur following injury and diseases of the nervous system. Is the pioneer of Stem cell therapy in India and has setup the Stem cell and Genetic research laboratory at the LTMG hospital & LTM Medical College. He has also created the NeuroGen Brain and Spine institute which is India’s fi rst dedicated Stem Cell Therapy and Neurorehabilitation Hospital. He has published pathbreaking results of Stem Cell therapy in Pediatric Neurodevelopmental disorders such as Autism and Cerebral palsy as well as in other conditions such as Muscular dystrophy and Spinal cord injury. He is the founder of the “Indian Journal of Stem Cell Therapy” and on the editorial board of 4 other journals. He is the Founding President of the “Stem Cell Society of India” and the Vice President of the “International Association of Neurorestoratology”. His other special interests include Revascularization surgery for cerebral ischemia, Psychosurgery, Stereotactic surgery, Neuroendoscopy, Spinal surgery and Neurotrauma.

stroke, CNS, Neurosurgery

Dr. Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.

Dr. Arvind G Kulkarni heads the ‘Mumbai Spine Scoliosis and Disc Replacement Centre’ as a Consultant Spinal Surgeon at Bombay Hospital, Mumbai, one of the oldest and largest hospitals of India. He has a vast experience in spinal surgery having trained in some of the top spinal centres across the globe such as KEM Hospital Mumbai, National University Hospital Singapore, Westmead Adult & Children’s Hospitals, Australia, St George Hospital – Australia and Toronto Western Hospital & Hospital for Sick Children Canada. He is one of the pioneers of Minimally Invasive Spinal Surgery in India (introduced Micro-Endoscopic techniques using the MetrX system for the first time in India in 2007). He is also one of the pioneers of Artificial Disc Replacement (name mentioned in Limca Book of Records for performing the first Artificial Disc Replacement [ProDisc-L] in the country)

Spine, neurology, Neurosurgery

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Associate Researcher at Basic and Clinical Neurosciences Research Labor & Vice President of SMNPH

Neurology And Neuroscience

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Geriatric Psychiatry, Addictions and Neuropsychiatry and Stroke Disorders

Patricio F. Reyes, MD is a board certified Neurologist and Neuropathologist, and director Barrow Neurological Institute’s Alzheimer’s disease (AD) and Cognitive Disorders Program, and Neuropathology Research Laboratory. Before joining BNI he was professor of Neurology, Pathology and Psychiatry and director of Creighton University’s Center for Aging, Alzheimer’s disease and Neurodegenerative Disorders, and Brain Bank and held similar positions at Jefferson Medical College in Philadelphia. He is the American Academy of Neurology advocate for Minority Americans with AD and other dementias. His interests include characterizing the clinical manifestations of Alzheimer’s disease and other dementias, and investigating the structural, anatomical and neurochemical substrates of neurobehavioral symptoms. He is involved in clinical trials for AD and has established clinical programs for Hispanic patients and minority caregivers. These programs are important in identifying ethnic related risk factors for AD, understanding the vulnerability of brain regions affected in AD, and verifying the safety, tolerability and efficacy of pharmacologic agents in various races. In the laboratory, he is currently involved in verifying the histological, immunohistochemical, electronmicroscopy, and metabolic changes in the brain parenchyma of triple transgenic mouse model of Alzheimer’s disease and Acetylcholinesterase knockout mouse. We expect to determine early physiologic and ultrastructural alterations that lead to neuronal loss and formation of neuritic plaques, and neurofibrillary tangles, and hope that our data will be relevant to the development of more effective therapies in AD.

Neurology

Dr. Giulio Maria Pasinetti, The Saunders Family Chair and Professor of Neurology, received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Director of the NIH funded Mount Sinai Center on the Promotion of Cognitive and Psychological Resilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He is also a Professor of Psychiatry, of Neuroscience, and of Geriatrics and Adult Development. Dr. Pasinetti is the recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. Most recently, Dr. Pasinetti was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.

Alzheimer's Disease Amyotrophic Lateral Sclerosis Diabetes Genomics Memory Obesity Parkinson's Disease

Prof. Abdulrauf is considered a leading figure in the field of neurosurgery. Neurosurgeons from around the world come to SLU throughout the year to be taught complex neurosurgical techniques by him. He has served as a visiting professor to over 100 universities around the globe. He has authored the main reference textbook for brain bypass surgery titled “Cerebral Revascularization” in which Dr. Abdulrauf details extra-cranial to intra-cranial bypass surgery. Additionally, he has pioneered a procedure for brain bypass that is named after him. He has served on the boards of multiple neurosurgical societies including the Congress of Neurological Surgeons (CNS), the North American Skull Base Society (NASBS), and the World Federation of Skull Base Societies (WFSBS). His most preeminent role was his appointment as the inaugural President of the Walter E. Dandy Neurosurgical Society, which is considered the primary international society for operative neurosurgery. He has been named as one of the Best Doctors in America annually for the last eight years. Dr. Abdulrauf’s opinion is routinely sought for the treatment of complex cases by neurosurgeons from around the world.

Neurology, Skull Base Surgery and Neurosurgery

Born in Jammu-Tawi, India. After receiving Bachelor’s degree in Pharmaceutical Technology from the Birla Institute of Technology, Pilani, India, Rameshwar K. Sharma in 1960 entered the University of Connecticut for graduate work in Medicinal Chemistry and received his Ph.D. in 1963. Subsequently, after several Post-doctoral positions, including at the Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts, he joined the University of Tennessee Medical Center at Memphis in 1970 where he rose to the rank of Full Tenured Professor of Biochemistry and Physiology. During this period through NIH Special Fellowship he spent two-years Sabbatical as a Visiting Professor at the McArdle Laboratory University of Wisconsin, Madison, in Dr. Henry Pitot’s lab, and subsequently additional two-years Sabbatical at the NIH, Bethesda in Dr. Michael Cashel’s lab. After Full Professorship at the Case Western University and Founder and Head of the Unit of Regulatory Biology at the Cleveland Clinic Foundation, Cleveland Ohio, he joined the University of Medicine and Dentistry at New Jersey as the Professor and Head of The Unit of Regulatory and Molecular Biology. Since July 2006 he is at the Salus University as a Distinguished Professor of Biochemistry and Molecular Biology. In a period spanning four decades, his research team has dedicated itself to the advancement of the field of membrane guanylate cyclase in the vertebrate systems. A few of its core findings that have impacted this and the field of cellular signal transduction follow. (1) With the discovery of the first membrane guanylate cyclase, ANF-RGC that was also the hormone receptor of ANF, the membrane guanylate cyclase surface receptor family was established. (2) It had a unique signal transduction mechanism. Instead of GTP in G-Protein signaling, it was regulated by ATP through its ARM module (ARM). The complete dissection of the module, followed through the concept-based analysis, localized a WTAPELL motif that controlled the entire signal transduction process, it was, then, predicted that this motif is the one that controls the ANF-RGC-dependent blood pressure in vasculature. This has now been proven true through the construction of the mouse genetic model. The mice lacking this motif are hypertensive. (3) The discovery and molecular characterization of the photoreceptor ROS-GC is a land mark event in the phototransduction field. It filled in the gap on the identity of the source of cyclic GMP that serves as a second messenger of the LIGHT signal; and made it possible to explain the principles of phototransduction in molecular and physiological terms. It also impacted the core membrane guanylate cyclase field by branching it into two: a transducer of both the hormone receptor and the intracellularly-generated Ca2+ signals. (4) ROS-GC field took additional direction when it was demonstrated that, besides phototransduction, it is biochemically linked with the transduction mechanisms of the inner segments of the retina, olfactory cilia and the olfactory bulb neurons. (5) The demonstration that ROS-GC is a Ca2+-bimodal switch, generated a new revolutionary concept where theoretically ROS-GC could be modulated through two different modes of Ca2+ signaling: via Ca2+-sensor GCAPS and S100B, the latter stimulating it and the mode found exclusively in cones and absent in rods. (6) Recently, an additional model of the photoreceptor ROS-GC1 has been disclosed. ROS-GC1 is responsive to the bicarbonate signal; it is not the pH effect, rather it binds to a specific motif of the ROS-GC and transduces the signal in generation of cyclic GMP. Preliminary findings suggest that this novel transduction system is present in a small number of mouse cones, and, importantly, is absent in the rods. This opens up a new area of sensory transduction mechanism, where it is meant to communicate with the external atmospheric carbon dioxide. The carbon dioxide is sensed through carbonic anhydrase, whose subtype has been detected in some cones, it converts CO2 to the bicarbonate, which, then, becomes the second messenger of CO2 and a signaling agent of ROS-GC1. Threaded through this past history and step-by-step gain in the field, This investigator feels fortunate that his group has made these important contributions in generating the field of membrane guanylate cyclase, establishing that cyclic GMP is an ubiquitous intracellular second messenger in prokaryotes and eukaryotes and that it plays a critical role in the control of physiological processes of cardiac vasculature, smooth muscle relaxation, blood volume, cellular growth, sensory transduction, neural plasticity, learning and memory. It is also gratifying to know that during this course he has been able to train and guide more than 35 doctoral and post-doctoral students, author 184 peer-reviewed research articles, including the editorship of three books, Special Editorship of two journals of Molecular and Cellular Biochemistry and the e-book editor of the Frontiers Molecular Neuroscience Research Topic, all focused on the field of membrane guanylate cyclases. At present I am on the editorial board of four international journals: Associate editor of the Frontiers in Molecular Neuroscience, Journal of Molecular and Cellular Biochemistry, Journal of Signal Transduction, Journal of Membrane Science & Technology.

Membrane guanylate cyclase in the vertebrate systems

Raymond Sekula, Jr., MD, joined the Department of Neurological Surgery on March 1, 2013 as an associate professor and director of the department’s Cranial Nerve Disorders program. Dr. Sekula is known internationally and nationally for his development of microvascular techniques, which provide patients with improved outcomes, reduced complications, and easier recoveries. He has been recognized with numerous honors, including The American Association of Neurological Surgeon’s Young Investigator Award, The Trigeminal Neuralgia Association Fellowship Award, and Pittsburgh Magazine’s “40 Under 40” and “Best Doctor’s” Award.

Trigeminal neuralgia, hemifacial spasm; skull base tumors, minimally invasive brain surgery.

M.D., Ph.D., Founder BMT (Brain Music Therapy) in US, Medical&Executive Director, BMT Center, NYC.

Attention Deficit Disorder (ADD) Bipolar Disorder Depressive Disorders

Dr. Roberto Federico Villa is an Associate Professor of Pharmacology of the Department of Biology and Biotechnology at University of Pavia (Italy) for degree in Biological Sciences and Chemistry. He is Doctor in Biological Sciences (D.Sc.), Medicine and Surgery (M.D.) Dr. Villa’s research interest on Physiopathology and Pharmacology of Central Nervous System Diseases (Aging, Hypoxia, Ischemia, Hyperammoniemia, Hypoglycemia, Depression, Parkinson) and drug’s interference on cerebral Bioenergetics and Molecular Medicine, by Functional Proteomics and Metabolomics of enzyme systems and on Dementia patients.

Dr. Villa’s research interest on Physiopathology and Pharmacology of Central Nervous System Diseases (Aging, Hypoxia, Ischemia, Hyperammoniemia, Hypoglycemia, Depression, Parkinson) and drug’s interference on cerebral Bioenergetics and Molecular Medicine, by Functional Proteomics and Metabolomics of enzyme systems and on Dementia patients.

Dr. Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.

Dr. Hallowell served more than eight years as Associate Dean for Research and Sponsored Programs in Ohio University’s College of Health and Human Services and six years as Director of the School of Hearing, Speech and Language Sciences. Given her extensive experience in boosting successful publication and extramural funding successes of students and faculty members, she is frequently invited to provide action-focused workshops on research career development and on ways to foster productive interdisciplinary and international collaboration in research and education.

Neurogenic Language Disorders, Global Health, Technology Transfer, Engaged Teeaching/Learning Methods

neurosurgeon barcelona fernando muñoz Dr. Fernando Muñoz Hernández Currently Attending Physician of the Neurosurgery Service of Hospital Santa Creu i Sant Pau . Tutor teaching. Secretary of the Skull Base Unit of the same hospital. Private practice in Clinical Teknon and Hospital de Barcelona since 2005 with Dr. Joan Molet (Head of Service of Hospital Santa Creu i Sant la Pau) Guards located at Hospital de Barcelona (Assistència Sanitària Col.legial) Bachelor of Medicine and Surgery from the Autonomous University of Barcelona ( Honours ) Specialized in neurosurgery as neurosurgery residency program (MIR) at the Hospital de la Santa Creu i Sant Pau and professor at the International University of Catalonia (UIC) . Observership in Department of Neurosurgery at the University of Miami with Prof. R. Heros External rotation in the Department of Neurosurgery at the Helsinki University Central Hospital in Finland Member and treasurer of the Catalan Society of Neurocirurgia Member of the Spanish Society of Neurosurgery Member and member of the Spanish Society of Skull Base Member of the Vascular Pathology of the SENEC active member of the Walter E. Dandy Neurosurgical Society. Member of the international AOSpine

Neurology And Neurosurgury

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU. His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury.

2014 to continue member of Scientific Committee of European Academy of Neurology 2014 to continue member (European representative) at Teaching Course Committee, World Federation of Neurology 2013-2014 Rector of University of Medicine, Tirana Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. 2010-2013 Health National Contact Point, European Commission, CORDIS Fp7 programme 2003 to continue: reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. February 2003 to continue – Trainer of European Academy of Epilepsy. 1998-2007 - President of Albanian Society of Neurology (ASN). 1997 to continue - Head of the University Service of Neurology (UHC Mother Teresa of Tirana) (75 beds). 1981 to continue - Lecturer: Faculty of Medicine, Neurology Department. University of Tirana (University of Medicine since January 2013). Neurology

Neuroscience and Neurology

Dr. Sanjoy Sanyal, Associate Dean, Neuroscience and Clinical Professor in Texila American University, Guyana, is a surgeon by profession, medical academician and educator by choice and medical informatician from UK by aptitude and inclination. He has more than 2 decades of surgical experience and more than 17 years of teaching experience in hospitals and medical universities in 11 countries worldwide. He is also an Honorary Faculty, Editor and Peer-reviewer of Neuroscience in WebmedCentral. He was solely responsible for setting up the Neuroscience department in two medical schools in Seychelles and in the Caribbean. This included curriculum development, syllabus, labs and clinical training in Neurological Examination. Additionally, he was the sole faculty in charge of the Student Surgical Association and was responsible for establishing the format for surgical skills training in medical schools. With more than 400 online brain dissection and Neuroscience videos online, which have received thousands of subscribers, Dr. Sanyal is a prolific teacher. With more than 35 scientific print publications and 11 papers presented in international conferences, Dr. Sanyal is a keen academic researcher. Dr Sanyal developed a Digital Brain Imager which enables a researcher or student to view the internal structure of the human brain by taking transverse slices through the head at 10 mm intervals from the top of the skull to its base. Dr. Sanyal also developed an electronic computer-based system for quickly establishing the Anatomical Stage of 26 cancers of the human body with just 4 mouse clicks. He presented this paper in Medicine X Conference in Stanford University School of Medicine in September 2012. This earned him a Provisional Patent from the United States Patent and Trademark Office (USPTO) in January 2013 and 2014.

His research interests lie in Digital Brain Imaging Technologies, Brain Dissections, Brain Digital Videos and Imaging Informatics.

Professor of Neurosurgery in the Updating Course supported by the University of Bari and the Apulia Region “Patient Management: Interrelation between Medical Physicians and Healthcare givers,” University Hospital of Bari, Italy SURGICAL SKILLS AND EXPERIENCE Performed over 4,500 neurosurgical operations of the following types: -cranial traumas (950) -spinal cord traumas (500) -benign and malignant endocranial tumours (1100) -benign and malignant spinal cord tumours (400) -hemorrhagic vascular pathologies (400) -cerebral abcesses (60) -cerebral and spinal parasitosis (30) -pediatric neurosurgery (300) -functional neurosurgery (50) -cervical, dorsal, lumbar disk hernias and degenerative diseases (900) MAIN RESEARCH AND SCIENTIFIC SKILLS RESEARCH PROJECT FUNDS INTERNATIONAL JOURNAL REFEREE MAIN CONGRESS PARTICIPATION MAIN PUBLICATIONS MAIN PUBLICATION RECOGNITION AWARD

Cranio-spinal neurotraumatology with clinical and experimental research in traumatic patients. Spinal neurosurgery in degenerative diseases with decompression and stabilization as well as reconstructive techniques. Oncological neurosurgery (cerebral and medullary) with anatomo-pathological and genetic studies. Vascular neurosurgery in the treatment of vascular malformations and haemorrhages. Neurosurgery in cerebral and spinal parasitosis. Pediatric neurosurgery with studies in the treatment of childhood malformations, tumours and vascular pathologies of the brain and spine. Functional neurosurgery with the application of beta-ray sources and the Argon laser in stereotactic therapy of degenerative, vascular and tumour pathologies.

She works as a medical neurophysiologist attached in the department of neurosurgery at the Hospital de la Santa Creu i Sant Pau (Barcelona ) , and mutual Terrassa , providing its services also through Neurotoc to patients via mutual or private .

Neuromonitoring, Neuroimaging , Neurology

Dr. Marco Lopes has experience practicing counseling, psychotherapy and research in behavioral neuroscience. He works with individuals, couples and families. He tailors his approach to each person’s unique life situation, background, and goals taking an interactive and supportive cognitive approach with an emphasis on what works. Marco helps people cope with transitions, trauma and loss, overcome depression and anxiety from personal or work stress and develop a sense of meaning and direction in life. He also researches the evidence of neuroendocrine-immune system interactions (spleen, thymus, bone marrow and lymph nodes) and changes in brain functions affecting different immune responses for a new clinical approach which perceives and treats the patient as a psychic and somatic whole. Specialties: Specialist in neuroendocrinoimmunology - Tokyo Metropolitan Ohtsuka Hospital Master of Neuroradiology Interventionnelle - l'Hopital Pitie-Salpetriere in Paris Specialist in General Psychopathology - Naippe / Institute of Psychiatry - Hospital das Clinicas FMUSP

Neuroscience and Phenomenology,Neuroimaging of Bipolar Disorder,behavioral neuroscience

Stephen L. Nelson, MD, PhD, FAAP, is dual Board Certified in Neurology with Special Qualification in Child Neurology and in Psychiatry and Neurology by the American Board of Psychiatry and Neurology. He has over 15 years of experience in the field of Pediatric Neurology and Pediatrics. Dr. Nelson is the current Director of Pediatric Neurology at Tulane Medical Center in New Orleans, LA, where he performs high volume inpatient and outpatient evaluations. He runs the pediatric epilepsy center which offers video EEG monitoring as well as epilepsy surgery. Dr. Nelson is also a full-time Associate Professor of Pediatrics, Neurology, Neurosurgery, and Psychiatry at Tulane University School of Medicine. He holds a medical license in the states of Louisiana, Mississippi, and Maryland and is certified as a medical doctor expert witness by the state of Florida.

Dr. Nelson provides consultations based on his knowledge and experience as a high-volume child neurologist and a highly recognized expert in: Attention Deficit Disorder (ADD, ADHD) Autism Birth Asphyxia Brain Development Abnormalities Cerebral Palsy Developmental Delay Concussion Electroencephalography Epilepsy Genetic Disorders Erb's Palsy / Birth Injury Headache Disorders Hypoxic Ischemic Encephalopathy Infantile Spasms Movement Disorders Movement Disorders Muscle Weakness Myasthenia Gravis Pseudotumor Cerebri Seizures

Accomplished leader with significant experience as researcher, professor and consultant in Drug Discovery and Academia. Significant contributions to discovering drugs, to increasing the understanding of drug action and to the biology of several diseases. Strong scientific, management and communication skills demonstrated in all endeavors. Established track record of building functional, cohesive research teams that are empowered to meet and exceed research goals. Specifics include: --25 years in Drug Discovery functioning as research team leader in developing and executing research strategies from target discovery to drug screening and target validation in disease to marketed drug and post-market drug scientific support; History of maintained/consistent research/resource support in industrial environment for disease target research and compound progression in Discovery Research. --Significant experience as consultant to Pharmaceutical Companies, and in the academic work environment helping to developing research direction, helping to secure federal research grant support and teaching. --Ability to Integrate Systems Pharmacology/Biology and Translational Medicine into Drug Discovery and Disease Biology Research. --Long standing research background/experience in cardiovascular and cerebrovascular diseases. --Member of journal editorial boards and NIH study groups; scientific reviewer to many journals, granting organizations and study groups/sections; member of numerous scientific societies; four faculty appointments; currently have published over 200 scientific manuscripts, reviews, chapters and patents.

Basic scientific study of Cerebrovascular diseases with focus on stroke, vascular cognitive impairment, risk factors, brain injury and restoration of function, and progression to dementia Development of animal models of human disease that can translate well to man and can facilitate our understanding of disease biology, pathology and cellular signaling Investigation of pharmacologic and other intervention approaches that reduce brain injury and restore lost brain functioning Pursue Biomarker Discovery required to impact drug discovery and advance therapeutic interventions Maintain close collaborations with Clinical Researchers and Neuroscientists in efforts to support Translational Medicine

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Addictions and Neuropsychiatry in Stroke

Marie Trad is an Executive Medical Director, acting currently as the Medical and Scientific Drug Development lead in Neurosciences within the CNS Therapeutic Delivery Unit at Quintiles. Trad is a board certified Neurologist and qualified Neuroradiologist from the Pierre and Marie Curie University of Paris, France. She has over 25 years of CNS experience of which 11 years as a clinical Neurologist/Neuroradiologist and 14 years of pharmaceutical industry, focusing on clinical trial management, providing medical, clinical and global strategic support related to Neurology and Psychiatry trials.

Drug Development in Neurosciences,Neuroradiology,clinical Neurology

Kaja is an experienced neurobiologist with a long-standing research track record in academia and the biotech and pharmaceutical industry. Kaja currently serves as Associate Director of Preclinical Research at the Vision Research Center at the University of Missouri - Kansas City, School of Medicine. He is the Director of Microscopy of the imaging core facility at the Vision Research Center and also holds an appointment to Assistant Professor of Ophthalmology. His NIH-funded research program focuses on human neurological and neurodegenerative diseases, visual disorders and inflammation. Kaja obtained his B.Sc. (Hons.) degree in Molecular Biology and Biochemistry from Durham University, UK and holds a Ph.D. degree in Medicine/Neuroscience from Leiden University, The Netherlands. Prior to joining the faculty at the University of Missouri - Kansas City, he has performed postdoctoral work at The University of British Columbia (Vancouver, B.C., Canada) and the University of North Texas Health Science Center (Fort Worth, TX). In addition to his academic work, Dr. Kaja has worked and consulted for a number of pharmaceutical companies, incl. Novo Nordisk A/S, Bayer AG, Neuromed Pharmaceuticals Inc., and NeuroSearch A/S. He is CEO and co-founder of K&P Scientific LLC, a scientific consulting company headquartered in Kansas City, MO.

Pathophysiological mechanisms underlying neurodegenerative, neurological and visual disorders.

Amina S. woods is an investigator at integrative neuroscience branch, structural biology unit, NIDA. Woods obtained her B.Sc degree in chemistry at Loyola College. After graduation, she joined Department of Pathology and went to University of Maryland Medical School and obtained her M.S. She received a Ph. D in Pharmacology and Molecular Sciences from Johns Hopkins School of Medicine. She has undergone Post-doctoral training in Oncology Immunology, Johns Hopkins School of Medicine (Advisor Elizabeth Jaffee). Dr. Woods received “Woman Scientist Achievement Award” from NIDA in 2011.

Functional proteomics, mapping and imaging of the brain’s and other organs, lipidome and proteome of leucocytes, protein modeling and bioinformatics

Maria Victoria Tejada -Simon is an Associate Professor of Pharmacology, Biology and Psychology, and member of the Biology of Behaviour Institute at the University of Houston in Houston, Texas. Current research in her laboratory examines the role of small GTP-binding proteins in cognition, with emphasis in mental retardation, schizophrenia, neurodegenerative as well as autistic disorders.

Pharmacology,Psychology,schizophrenia,neurodegenerative disorders

Jerzy Leszek is full professor of psychiatry at the Medical University in Wroclaw , Poland ,vice –director of the Psychiatry Department and head of Alzheimer’s Disease Lab. He is author and co-author more than 210 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and seven another academic handbooks from psychogeriatry , member a lot of scientific associations eg founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland and Former Member of Board of Directions of International Psychogeriatric Association and President of Polish Psychogeriatric Association.

Psychiatry,Alzheimer’s Disease

Fakhir Al-Ani has completed his M.Sc. study and PhD study from Baghdad University ,College of Medicine. School of Medicine. He spend about 30 yars as a teaching staff in medical college. He is now working in Mutah University, Medicl College as the head of Physiology & Pathology Dept. He has supervised more than 13 Ph.D thesis, and more than 23 M.Sc. thesis. He has published more than 35 papers in reputed journals.

Neurophysiology/ Electrophysiology EEG, EMG, Evoked potential

Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 30 peer-reviewed journals.

Identification of candidate therapeutics for Amyotrophic Lateral Sclerosis, Huntington’s disease, and ischemic stroke; Fundamental mechanisms of neurological diseases.

Guangping Gao, Ph.D., is the Director of the Gene Therapy Center and Penelope Booth Rockwell Professor in Biomedical Research, UMass Medical School. He is also a scientific founder of Voyager Therapeutics. He received his Bachelor Degree in Medicine from Sichuan University, China, and Ph.D. in molecular genetics at Florida International University with his work on discovering the human aspartoacylase gene and the genetic mutations responsible for Canavan’s disease. He joined the Institute for Human Gene Therapy (IHGT) at University of Pennsylvania in 1994 and served as the Director of Vector Program of IHGT for vector discovery, process development, vector manufacturing and QC testing. One of his most important contributions to the field of gene therapy is his discovery of a novel family of highly efficient and safe AAV vectors. His primary research interests include molecular mechanisms of AAV evolution, microRNA functional genomics in adult mammals, biology and clinical applications of miRNA therapeutics, and gene therapy of CNS disorders. He has published more than 150 papers in peer-reviewed journals and has 26 patented inventions. He served on several international committees for gene therapy. He is the senior editor of the Book Series on Gene and Cell Therapy publishing by ASGCT and Springer Publisher and serves on Advisory Board of Advances in Experimental Medicine and Biology

Molecular mechanisms of AAV evolution, microRNA functional genomics in adult mammals, biology and clinical applications of miRNA therapeutics, and Gene therapy of CNS disorders

Guang-Xian Zhang earned his Ph.D from Karolinska Institute, Stockholm, Sweden, in 1996 and began postdoctoral studies at the University of Pennsylvania School of Medicine in 2000. He is currently professor at the Department of Neurology, Thomas Jefferson University, and co-director of the Neuroimmunology Laboratories at this institution. He has published more than 80 peer-reviewed papers. He has also served as a reviewer for first-class journals, and as a reviewer on study section rosters in several funding agencies. His studies mainly focus on using neural stem cells as a novel approach for treatment of human multiple sclerosis, via mechanisms of immunomodulation, neural cell repopulation and neuroregeneration.

Neural stem cells/gene therapy in multiple sclerosis (MS), Neurological autoimmune diseases

Education / Training 1986 - Ecole Normale Superieure (Life Science). 1991 - Ph.D. Neuroscience (Bordeaux University). 1998 - Habilitation (Paris XI University, School of Medicine). Present Position Head of the Laboratory \\\\\\\"Perception and Memory\\\\\\\" at the Pasteur Institute Director of the Unit \\\\\\\"Genes, Synapses and Cognition\\\\\\\" at the French Center for Scientific Research (CNRS) Director of a PhD program \\\\\\\"Neuroscience at the Pasteur Institute\\\\\\\"

Modern neurosciences

Rafi is a Professor of Neurology at Thomas Jefferson University, Philadelphia. He has received his PhD in Animal Biology from the University of Montpellier, France. He has taught Cell and Molecular Biology for 16 years at the School of Science, Tabriz University, Iran where he sustained the Chairmanship of the Biology Department for several years before moving to the USA. While working in several lysosomal storage diseases, his main research is currently focused on gene therapy of globoid cell leukodystrophy (Krabbe disease) in animal models of this disorder

Lysosomal disorders, Gene & cell therapy of leukodystrophies

Dr. Trevor Archer is a Professor of Psychology in University of Gothenburg, Sweden. He did his PhD, in Psychology from the Uppsala University, Uppsala, Sweden in 1979. He served as a Professor of Psychology in Umeå University, Göteborg University, Karlstad University, Örebro University, Madrid Complutense, Kalmar University, Sweden, Visiting Professor, University of Hawaii at Manoa, USA; Madrid University, Spain, La Sapienza University, Rome, Italy. Dr. Archer is an author of more than 484 publications & many books. He is an Editorial Board member & Reviewer for many Journals.

Psychology,Neurotoxicity Research

Walter E. Muller is a Professor of Pharmacology.He is now serving as a Chairman, Department of Pharmacology,Biocentre,University of Frankfurt.He is graduated from School of Pharmacy,University of Frankfurt with a Doctoral degree in department of pharmacology from University of Mainz school of medicine.He is a Honorary member of Austrian Society for Neuro Psychopharmacology and Biological Psychiatry and was awarded in Psychopharmacology,German Association for Neuropsychopharmacology(AGNP)in 2009,Award in German Secretary for Science and Education in 1978.He has a Fellowship in American College of Neuropsycho-pharmacology. He had published 21 Books,129 Book chapters.Reviewed 189 Articles,has 320 Original publications with Hirsch-index: 63 & i10-index: 278.

Neurodegeneration and neuroprotective agents, Oxidative stress and antioxidants, Anti-depressant and anxiolytic mechanisms

Dikranian is an Associate Professor of the Department of Anatomy & Neurobiology in Washington University , USA. He received his MD from Medical University, Varna, Bulgaria in 1978 & PhD from Medical Academy, Sofia, Bulgaria in 1992. Dikranian have extensively studied the morphology of the vascular and nervous systems including the enteric nervous system. In the last 15 years the focus of his scientific interest has been the pathomorphology of the central and peripheral nervous systems. In ongoing projects with the Department of Neurology I am studying the development of neuronal and axonal changes after brain trauma and in transgenic mice expressing mutations common in Alzheimer’s disease. Mapping the human macro-connectome represents a grand challenge for the coming century and the field of connectomics received a major boost with the launching of the Human Connectome Project (HCP) in 2010. This is a large-scale NIH-sponsored effort to map the human connectome in healthy adults. Diffusion imaging and resting-state fMRI represent the two main modalities for examining the macro-connectome in vivo. My contribution to the project relates to combining and navigating MRI data with data from histological studies on primates by tracking trajectories of axonal pathways between the white matter and gray matter. Dikranian been a reviewer for many reputed Journal & author for many publications & books.

Pathomorphology of the central and peripheral nervous systems.

Meguid is an experienced clinical geneticist . Currently served as a professor of human genetics at the National Research Center (NRC) in Egypt. Holds her Ph.D. in Human Genetics, Senior Geneticist at the Genetics Institute, Pasadena, California; a fellow of Uppsala University, Sweden; fellow at Yale University USA. She was one of five selected scientists to win the outstanding L’Oreal UNESCO Award for women in Science for Africa & Middle East (2002). She is the head and running a Clinic and Laboratory for children with neurogenetic disorders focusing on genetics of autism. Currently she is a member in the Regional Bio-Ethics Society and committed to Gender Research in Africa into Information Communication Technologies for Empowerment.

Neurodevelopmental research particularly autism, syndrome identification

Carlos Jorge Rubinstein is a Professor of Medicine at Universidad de Buenos Aires (UBA)and Head of Teaching and Research at Hospital Dr. F. Abete. Dr. Rubinstein was born in Buenos Aires, Argentina, studied at the Faculty of Medicine of the University of Buenos Aires. He received his medical degree in 1990. He completed his residency at the Hospital Dr. Ramon Carrillo. It Intern Medicine specialist, Psychiatry and Geriatrics. Teaching UBA School of Medicine, director of graduate studies in geriatrics at this university. Staff in Trauma and Emergency Hospital Dr Federico Abete (teaching Hospital), Head of Teaching and Research at same hospital. He is a member counselor of the Colegio Medico of the Province of Buenos Aires, a member of the Society of Internal Medicine of Buenos Aires and mamber of Argentina Medical AssociationBiography

Psychiatry, Medical Psychology, and GeriatricsResearch Interest

Yusaku Nakabeppu is a Professor at the Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Japan. He is now serving as the Director of Research Center for Nucleotide Pool, Kyushu University. Dr. Nakabeppu graduated from Graduate School of Sciences, Kyushu University, with a Doctor of Science degree in 1984. He has performed postdoctoral work at Johns Hopkins University School of Medicine (in Professor Daniel Nathans’s Lab; 1987 to 1990). In 1997, he was appointed as a Professor at the Medical Institute of Bioregulation, Kyushu University, and elected as a Distinguished Professor at Kyushu University in 2010.

Neurofunctional genomics

Education 1988 BSc in Biological Sciences, University of Milan 1992 PhD Degree in Molecular and Cellular Biology, University of Milan Professional experience 1992-1997 Postdoctoral fellow, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany 1998 – to present Group Leader, San Raffaele Scientific Institute, Milan, Italy 1998 – to present Professor of Psychobiology, University San Raffaele, Milan, Italy 2003 – to present Council Member of the Molecular and Cellular Cognition Society 2006 – to present President of the European Molecular and Cellular Cognition Society 2007 – to present Editorial Board Member of Frontiers in Behavioral Neuroscience

Neurosciences,Dysfunctions associated to Parkinson’s disease